Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera
- REVIVE Trial Investigators
- Icahn School of Medicine at Mount Sinai
- Medicine
- Medicine - Hematology and Medical Oncology
- Mount Sinai Academy of Physician-Scientists
- Center for Advancement of Blood Cancer Therapies
- Cancer Clinical Investigation
- Graduate School of Biomedical Sciences
- Institute for Translational Medicine and Pharmacology
- Mount Sinai Tisch Cancer Center
- Institute for Regenerative Medicine
- Black Family Stem Cell Institute
- Friedman Brain Institute
- Hematology-Oncology, Infectious Diseases, Palliative Care, Psychology, and Nutrition
Research output: Contribution to journal › Article › peer-review
47
Scopus
citations